Introduction
With the wide use of radioactive materials in medicine, industry and agriculture, human beings are facing more unexpected radiation combined injury, of which the refractory skin wound healing remains a great challenge to clinicians. The mechanisms underlying radiation combined injury-impaired wound healing include declined inflammatory cells in the wound and reduced growth factors and collagen synthesis. 1, 2 A persistently open wound is easily colonized by microorganisms, which aggravate the wound microenvironment and create an vicious cycle of chronic wound. A level equal to or greater than 10 6 organism per gram of tissue is strongly related to impaired wound healing. [3] [4] [5] [6] [7] It has been demonstrated that bone marrow-derived mesenchymal stem cells (BMSCs) can promote the healing of compromised wound, 8, 9 probably because of their plasticity in differentiation, 10 ,11 secreting cytokines and growth factors critical to wound healing, 12, 13 low immunogenic property 14 and immunomodulatory function. 15 BMSCs are demonstrated to be potent carriers for exogenous genes. Platelet-derived growth factor (PDGF) is one of the growth factors appearing early in wound healing. It promotes granulation tissue formation and collagen deposition and has an important role in wound healing, 16 including that from diabetes, 17 malnutrition 18 or radiation. 19 Expression of exogenous PDGFs in BMSCs may help overcome the rapid degradation and repeat administration of PDGFs by continuous release in situ. Human beta-defensin2 (hBD2), expressed by keratinocytes, when stimulated by interleukin-1b, tumor necrosis factor-a and microorganisms, 20, 21 is an important component of innate defense system of the skin because of its potent antimicrobial activity against bacteria, enveloped viruses and fungi. Defensins regulate adaptive immunity and chemoattract phagocytes and mast cells, and stimulate epithelial cell proliferation at low concentration without inducing acquired resistance as traditional antibiotics, hinting that it is an antiinfectious candidate for refractory skin wound.
To explore countermeasures to promote chronic wound healing, a recombinant adenovirus vector simultaneously expressing hPDGF-A and hBD2 was constructed to modify BMSCs, which were transplanted to the wound site of rats with combined radiation-wound injury and the promotive effects on wound healing were confirmed.
Results

Expression of transgenic hPDGF-A/hBD2 at mRNA and protein levels in BMSCs
To render the BMSCs with mitogenic and antibiotic abilities, we constructed recombinant adenovirus vectors expressing hPDGF-A as well as hBD2 at the same time, and the BMSCs were infected with the recombinant adenovirus. After virus infection, more than 95% of the target cells expressed green fluorescent protein (GFP) as an indicator of successful infection. Expression of hPDGF-A or hBD2 mRNA in BMSCs infected with the recombinant adenovirus was examined by means of reverse transcriptase-PCR. The RT-PCR products of the expected 678-bp hPDGF-A fragment and 195-bp hBD2 fragment confirmed at mRNA level, their expression in BMSCs containing recombinant exogenous genes (T-MSCs), whereas they were not detectable in normal BMSCs (N-MSCs) and BMSCs containing only delivered GFP (control BMSCs (C-MSCs); Figure 1a ). Conditioned media (CM) were collected from the three kinds of cells above, correspondingly named T-CM, N-CM and C-CM. The hPDGF-A and hBD2 protein in the CM were identified by western blot. Consistent with mRNA expression, the expected 24-kDa hPDGF-A and 4-kDa hBD2 proteins were present only in CM from T-MSCs (T-CM), but were not detectable in CM from normal or vector control-infected cells (Figure 1b) . These results indicate that the transgenic hPDGF-A/hBD2 proteins were successfully expressed in BMSCs.
Functionality characterization of transgenic hPDGF-A/hBD2 proteins
Cell counting assay, using cell counting kit-8 (CCK-8), was performed to test the effect of different CM on the proliferation of BMSCs. From the cell growth curve, it was revealed that T-CM induced significant cell proliferation from day 2 to 5, compared with N-CM and C-CM. There was no obvious difference between N-CM and C-CM through the duration of observation (Figure 2a) . To test the contribution of hPDGF-A in T-CM, neutralizing hPDGF-A antibody was applied to the medium (T-CM/Ab). As a result, significant cell growth inhibition was obtained on day 4 (Po0.01) but not on day 2 although the addition of antibody was not able to completely block the increased cell growth when compared with N-CM or C-CM. Consistent results were obtained from direct cell counting (data not shown). Scratched monolayer cells were applied to test the promotive effect of different CM on wound healing. The results of this assay showed that the healing ratio of T-CM was significantly higher than that of N-CM and C-CM at 8, 12, 24 and 30 h after scratching (Figure 2b) . The migrated cells with T-CM treatment almost completely covered the vacant area at 30 h, whereas about twothirds of the wound area were left empty in cells treated with N-CM or C-CM. Neutralizing hPDGF-A antibody intervention (T-CM/Ab) partially inhibited T-CM-stimulated wound healing, but still showed significantly faster wound healing than N-CM or C-CM treatment.
The antibiotic activity of expressed hBD2 in hPDGF-A/hBD2 gene-modified BMSCs was confirmed by Kleihauer-Betke (K-B) assay on Pseudomonas aeruginosa (PA), Escherichia coli (EC) and Staphylococcus aureus (SA). The concentrated CM with 10% trypsin in the filter disks were put on the surface of agarose Luria-Bertoni spread with the above three representative strains of bacteria. hPDGF-A/hBD2 gene-modified BMSCs promote wound healing L Hao et al There were obvious bacteriostasis circles around the filter disks containing condensed T-CM, indicating an antibiotic effect from such cells. However, there is no antibiotic effect observed in the filter disks that were treated with either N-CM or C-CM (Figure 3 ). These results indicate that the transgenic hPDGF-A/hBD2 proteins are functional.
Transplantation of hPDGF-A/hBD2 gene-modified BMSCs accelerated wound healing
Combined radiation-wound injury, the delayed wound healing model, was created as 6 Gy total body irradiation (TBI) plus excisional skin wound of 2% total body surface area. Our preliminary study confirmed that this kind of simple excisional wound in non-irradiated rats usually healed around 17-18 days. The average healing time in irradiated rats treated with hPDGF-A/hBD2 gene-modified BMSCs (group T) was around 21 days, and those of group N (rats treated with N-BMSCs) and group S (sham-treated rats) were between 24 and 25 days and between 27 and 28 days, respectively. The wound healing condition of rats in different groups at day 21 post-transplantation was representatively shown in Figure 4a . After scar shedding and complete re-epithelialization, the wound was recognized as a healed wound, although there was still an area left without hair. The percentages of residual wound area of groups T hPDGF-A/hBD2 gene-modified BMSCs promote wound healing L Hao et al and N were significantly smaller than that of group S at days 14 and 21 (Po0.01) post-transplantation. Although the implantation of gene-modified BMSCs resulted in a tendency of being healed better than under N-BMSC treatment, there was no statistical significance between groups N and T in the first 2 weeks after injury ( Figure  4b ), indicating that BMSCs alone could facilitate wound healing. The earlier scar shedding and re-epithelialization in group T around day 21 finally revealed faster wound healing than group N (Po0.01), which demonstrated the possible benefit from the expression of exogenous genes. Histological observation on hemotoxylin-eosinstained wound tissues confirmed better granulation formation in group T ( Figure 5 ). The epithelial cells proliferated actively and showed a multilayer structure that covered the wound bed toward its center 7 days post-wound. At this time, angiogenesis rarely occurred in groups N and S. However, there were much more small vasculatures within the granulation tissue in group T when compared with group N as well as with group S. Blood congestion and hemorrhage could be seen obviously in group S, mildly in group N and rarely in group T. The cell content in granulation tissue of group T on day 7 was higher than that of other groups, so the contribution of mitogenic effect of overexpressed hPDGF-A should be counted in addition to the transplanted cells. At 2 weeks after injury and treatment, the granulation tissues of group T were mostly replaced by fibroblasts and newly deposited red-stained collagen Figure 4 Human platelet-derived growth factor-A (hPDGF-A)/human beta-defensin2 (hBD2) promotes wound healing in vivo. (a) Wound healing condition with different bone marrow-derived mesenchymal stem cell (BMSC) transplantation at day 21 in vivo. The animal model with radiation-wound injury was generated as described in Materials and methods. The wound at day 21 in rats treated with gene-modified BMSCs was almost invisible, whereas in the other two groups it was still clearly observed. (b) Comparison of the percentage of residual wound area in different treatments (n ¼ 8). Combined radiation-wound injury of 6 Gy total body irradiation (TBI) and skin excision of 20 mm diameter was locally injected with gene-modified BMSCs, normal BMSCs and phosphate-buffered saline (PBS). The healing rate was calculated. At day 7 and thereafter, BMSC-treated wounds healed faster than PBS control, whereas gene-modified BMSCs showed a tendency of being healed better than normal BMSC treatment. At day 21, the residual area in group T was significantly smaller than that of group N, which was mainly the result of the earlier scar shedding in group T.
m Po0.05, Histological study on hemotoxylin-eosin-stained radiation-wound tissues. Inserts were amplified local areas from the same images. The comparable images from the sections of each group were taken to include the wound edges and frontiers of migrated epithelial cells. Blood congestion and hemorrhage could be seen obviously in group S, mildly in group N and little in group T, 7 days after injury (upper panel). Meanwhile, the actively proliferated epithelial cells formed a multilayer structure (white triangle) that migrated to the center of the nude wound bed and obvious angiogenesis (black triangles) within the granulation tissue of group T, but to a less extent in group T and even less in group S. At 3 weeks after injury and treatment (lower panel), the wound bed was completely re-epithelialized with regenerated skin appendages (arrows) in group T, but the re-epithelialization and regeneration of skin appendages were present to a lesser extent in group N but not yet present in group S. Dashed lines indicate the interface of the wound bed and unwounded skin. W, wound site. bars ¼ 100 mm.
hPDGF-A/hBD2 gene-modified BMSCs promote wound healing L Hao et al fibers, and the wounds were nearly re-epithelialized. The epidermis of group N was thinner when compared with that of group T. The wound in group S still remained in prolonged granulation tissue formation. At 3 weeks after injury and treatment, the wound bed was completely reepithelialized with regenerated skin appendage in rats of group T, and the regeneration of skin appendage was, to a less extent, present in group N but not yet in group S. The granulation tissue was more matured in group T, as indicated by less cellularity and more extracellular matrix deposition, than those in other groups. Locally transplanted gene-modified BMSCs were traced with their GFP fluorescence under a fluorescent microscope. Snap-frozen and instantly made sections facilitated the direct allocation of the transplanted cells. On day 7 post-wound, transplanted BMSCs were scattered in the tissue in addition to the cell clumps at the sites of injection. Even 14 days after transplantation, it was still possible to find some cell clumps showing weaker green fluorescence, which indirectly indicated the expression of exogenous genes that were driven by the same promoter.
Transplantation of hPDGF-A/hBD2 gene-modified BMSCs facilitated collagen deposition and maturation in wound healing
Collagen deposition and maturation reflect one aspect of the quality of wound healing. PDGF-A is known for its effects on stimulating cell proliferation and extracellular matrix synthesis. The application of Sirius red staining to the tissue section was to test the effects of exogenous hPDGF-A on collagen information during wound healing and to reflect the quality and quantity of wound healing. When stained with Sirius red, collagen type I showed a red or yellow color, whereas collagen type II showed green under polarized light microscopy. As the normal skin dermis constitutionally contains a significant amount of collagen and showed bright red color, the wound beds were easily distinguished from the unwound skin nearby (Figure 6a) . The results showed that collagen deposition began at 7 days and was mainly type I collagen in our combined injury model. There were much more fibers of collagen type I and the fibers were thicker in group T, especially at 21 days after injury. At this time point, the animals in group T showed that the arranged collagen network and red refractive power were closer to normal pattern, but the animals in other groups did not do so. This parameter also revealed the difference underneath the re-epithelialized wound sites among groups. The mean optical density (OD) value, which semiquantitatively reflected the gross collagen content in the tissue section by image processing software, derived from group T was significantly higher than that from other groups all the time, whereas the value in group N was higher than that in group S from day 7 to 14 ( Figure 6b ).
Transplantation of hPDGF-A/hBD2 gene-modified BMSCs decreased colonization of bacteria during wound healing
Infection is always one of the main reasons causing difficulty in wound healing. To evaluate in vivo antibiotic activity of recombinant hBD2, the amount of bacteria under the scar at different times was measured. It was found that the mean number of bacterial colonies in group T was much lower when compared with group S at all the time points and with group N at days 14 and 21 ( Figure 7) , which was in agreement with in vitro K-B test. Although primary BMSCs did not contain hBD2, the accelerated wound healing in group N may contribute to less bacterial load when compared with group S.
Discussion
Our previous dose-effect studies showed that a radiation dose greater than 4 Gy TBI will significantly delay wound repair. 22 The mechanisms underlining prolonged wound healing include, but are not limited to, a decrease in the total number of inflammatory cells and in the cells recruited to the wound site, wound-repairing cells, and the synthesis and secretion of various pro-healing factors. According to our experience, 6 Gy TBI plus the excisional wound of 2% total body surface area in rats, provided a reliable model of chronic wound healing to investigate the molecules concerned and to test the efficacy of novel therapies. The in vivo wound healing study shows that the implantation of both kinds of BMSCs was able to accelerate wound healing. Genemodified BMSCs showed a tendency of being healed better than N-MSC treatment and exhibited an earlier scar shedding.
Much more attention has been paid to gene therapy for chronic wounds. Viral and non-viral vectors have been applied to introduce various transgenes, including PDGF, vascular endothelial growth factor, basic fibroblast growth factor and transforming growth factor-b into chronic wounds in animal models 23 to circumvent the limitations of direct application of recombinant proteins, such as rapid degradation. Recombinant adenovirus-delivered transgenes express in a non-persistent, non-integrated manner. 24, 25 By tracing the GFPpositive cell, we were able to locate the cells and expression level of exogenous genes. Because hPDGF-A/hBD2 and GFP were independently driven by the same kind of PGK promoter, it was reasonable to deduce that the expression of exogenous hPDGF-A and hBD2 in vivo should last for at least 2 weeks. This result was confirmed by immunohistochemistry staining on wound tissue section for both hPDGF-A and hBD2 (data not shown). These results provide further evidences to support the relationship between the upregulated hPDGF-A/hBD2 expression and the promotive effects observed on wound healing from the modified BMSCs. Although hBD2 in vitro was activated in the presence of trypsin, in vivo it would be activated by proteases present in the wound fluid. The homology of full-length human PDGF-A and its rat counterpart is about 86%; meanwhile, if the extra basic motif in hPDGF-A is excluded, the homology increases to about 93%, which is consistent with the biological activity observed in our animal experiment.
Cell therapy, mainly keratinocyte or fibroblast transplantation in the past, and BMSCs in recent years, have been applied to chronic wounds for many years. In our experiment on rats with combined injury, the better granulation tissue formation and collagen deposition were ranked in the following order: hPDGF-A/hBD2 gene-modified BMSCs4N-MSCs4phosphate-buffered hPDGF-A/hBD2 gene-modified BMSCs promote wound healing L Hao et al saline (PBS) control. This cohort not only exhibited the known effects of BMSCs accelerating wound healing but also suggested the additional benefit of hPDGF-A/hBD2 expression. Although some of the parameters showed statistical significance between groups T and N, it was still difficult to draw clear conclusions of the synergistic effects of cell therapy and gene therapy in this smallscale animal test. Histological studies produced more supportive evidences: less blood congestion and hemorrhage, more cell content and angiogenesis in granulation tissue in early stages of wound healing; more skin appendage regeneration, better collagen deposition and maturation in late stage. It was demonstrated that recombinant adenovirusinfected BMSCs could survive and express exogenous genes in the wound microenvironment for at least 2 weeks on the basis of the GFP reporter. Thereafter, owing to episomal state of adenovirus and its dilution effect on transgenes during cell division, the expression may gradually diminish but the cells may survive and integrate into reparative tissue. We noted that the bacterial colonies in group T were much less than in other groups at day 7 and that the differences among groups were to a lesser extent later on. In the early stages of wound healing, the open wound provides a nutrient medium for bacterial colonization, if not interfered with. This stage provides exogenous hBD2 a time window to show its antibiotic effect, because the transplanted cells are active in vitality and gene expression during this period of time, as indicated by GFP expression. Once the dry scar forms, it not only deprives the bacteria of nutrition but also prevents further infection. Meanwhile, the expression of hBD2 might gradually decrease and result in less antibiotic effect than before. The fact that more granulation tissue and collagen deposition and less bacterial colony counts under the scar in rats transplanted with hPDGF-A/hBD2 gene-modified BMSCs suggested the advantage of this gene therapy, which Figure 6 Collagen deposition in wound sites at 21 days after injury. Sirius red-stained wound sections from different time points were analyzed by polarized light microscope to assess collagen fibers and their alignment. (a) Typical collagen staining of sections from different groups. Normal skin dermis (brighter area) was easily distinguished from unwound skin nearby (darker area). The dashed squares in figures of the upper panel indicate amplified areas in the lower panel. Compared with the other two groups, there were much more fibers of collagen type I that showed red and yellow color because of its birefringence, and the fibers were thicker. Bars ¼ 100 mm. (b) Collagen contents in wound tissue. Sirius red-stained sections were photographed and the images were analyzed for quantifying the collagen content in wound tissue. From days 7 to 21, the collagen contents in group T were significantly higher than in the other two groups, whereas those in group N were significantly higher than those in group S at days 7 and 14.
mm Po0.01 vs group S; WW Po0.01 vs group N.
hPDGF-A/hBD2 gene-modified BMSCs promote wound healing L Hao et al provided the wound tissue with reparative cells (BMSCs) as well as the pro-healing factors (hPDGF-A and hBD2). This proper combination of cell therapy and gene therapy, based on the properly selected exogenous genes, may have potential in regeneration medicine. As we showed in this study, combined hPDGF-A and hBD2 has shown their synergistic effect of promoting wound repair through different pathways. The study on different differentiation destinations of transplanted BMSCs is one of our ongoing projects. In this study, we showed that hPDGF-A/hBD2 genemodified BMSCs were established by recombinant adenovirus infection and were locally transplanted onto the site of combined injury. In certain cases, this combination of cell therapy and gene therapy showed better combined effect over the transplantation of NMSCs alone. The evaluation of this combined effect needs large-scale and intensive animal tests. Further study is needed to explore the mechanism of promoting wound healing by BMSCs and their derivatives with gene modification.
Materials and methods
Preparation of recombinant adenovirus vector
Full-length cDNA of hPDGF-A flanking with EcoRI and BamHI endonuclease sites, obtained by PCR using plasmid pLXSN-hPDGF-A (kindly provided by Dr G Yan, TMMU, Chongqing, China) as the template, was inserted into a multiple cloning site of plasmid pIRES 2 -EGFP. The hPDGF-A-IRES fragment was sequenced and amplified by PCR to clone this fragment into BglII and NotI cutting sites in shuttle vector pAdTrack-CMV-hBD2 (a gift from Dr N Li, TMMU). The infectious recombinant adenovirus particles were collected after homologous recombination of shuttle vector with Adeasy-1 in BJ5183 cells and packaged in 293 packaging cells.
Infection of BMSCs
Isolation and culture of rat BMSCs were carried out according to the standard methods. 26 For infection, the cells at passage 3 were grown in 75 cm 2 culture flasks to 80% confluence, replaced with fresh non-serum media containing recombinant adenovirus. After incubation for 2 h, fresh complete media were added. Expression of enhanced GFP in gene-modified BMSCs was observed daily using fluorescent microscopy. In BMSCs infected by recombinant adenovirus Adv-hPDGF-A/hBD2-GFP, the expressions of exogenous gene of hPDGF-A/hBD2 at mRNA and protein levels were demonstrated by RT-PCR and western blot. CM were harvested from cultured N-MSCs, BMSCs infected by Adv-GFP (C-MSCs) and BMSCs infected by recombinant adenovirus AdvhPDGF-A/hBD2-GFP (T-MSCs) for testing the activities of expressed proteins by CCK assay, wound-healing assay on monolayer cells and K-B method.
RNA isolation and RT-PCR analysis
Total RNA from N-MSCs, C-MSCs and T-MSCs was isolated using the standard acid phenol/guanidine isothiocyanate procedure (Roche, Indianapolis, IN, USA) and reverse transcribed using the M-MLV reverse transcription kit (Invitrogen, Carlsbad, CA, USA). PCR primer pairs were as follows: for hPDGF-A, forward (5 0 -TCGAAGCTTGAATTCATGAGGACCTTGGCTTGCC TG) and reverse (5 0 -TACGGATCCCTCGAGTCACCTCA CATCTGGTTGGCTG); for hBD2, forward (5 0 -TCGAC CAGATCTATGAGGACCTTGGCTTGCCTG) and reverse (5 0 -ATGCTCGCGGCCGCGGTTGTGGCCATATTATCATC).
Exogenous gene expression detected by western blot
To test the exogenous hPDGF-A and hBD2 expression and secretion, 1 Â 10 6 cells of N-MSCs, C-MSCs and T-MSCs were separately seeded in 10-cm cell culture dishes in Dulbecco's modified Eagle's medium/Ham's F12 medium with 10% fetal bovine serum. After 24 h, the medium was changed to Dulbecco's modified Eagle's medium/Ham's F12 medium without fetal bovine serum, and the culture was continued for another 24 h. Then the culture supernatants were collected and correspondingly named T-CM, N-CM and C-CM. CM were concentrated by using the protein concentration kit II (Applygen Technologies Inc., Beijing, China). Protein concentration was determined using the Bradford dyebinding assay with bovine serum albumin as the standard. Total protein (30 mg per lane) was resolved on SDS-polyacrylamide gel electrophoresis and transferred onto a nitrocellulose membrane and incubated with anti-hPDGF-A (1:200) and anti-hBD2 (1:200) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA), followed by incubation with corresponding secondary antibodies. The bands were visualized by using the enhanced chemiluminescence system (Pierce, Rockford, IL, USA).
Wound-healing assay
10T1/2 cells (ATCC mesenchymal stem cells) were cultured to 90% confluence in 24-well dishes with a marker line drawn on the bottom. Using a sterile 20 ml pipette tip, the scratched wound was made through the monolayer cells. Cells were rinsed with PBS and 100 ml of the above CM was added to the cells. Besides, another Figure 7 The antibiotic effect of human beta-defensin2 (hBD2) in vivo. Tissue samples under scar were homogenated and cultured for bacterial colony formation (n ¼ 3). Each sample was cultured in triplicate. At day 7 and thereafter, group N (bone marrow-derived mesenchymal stem cell (BMSC)-treated wound) showed less bacterial colonies than group S, and group T (Human plateletderived growth factor-A (hPDGF-A)/hBD2-modified BMSC-treated wound) showed even less bacterial colonies than group N. 
Cell proliferation assay
The primary BMSCs at passage 3 were seeded into 96-well culture plates at 2 Â 10 3 cells per well in 100 ml of Dulbecco's modified Eagle's medium/Ham's F12 containing 10% fetal bovine serum. After incubation for 24 h, the cells were transferred to 100 ml of the above different CM. Cell proliferation was determined in triplicate for each CM treatment by CCK-8 in the following 7 days. Briefly, 10 ml of the CCK-8 solution was added to each well, and the culture was continued for another 2 h. Values of OD were determined using a microplate reader at a wavelength of 450 nm. To test the contribution of expressed hPDGF-A in stimulating cell proliferation, T-CM plus hPDGF-A-neutralizing antibody (T-CM/Ab) was set up, in which 2 ml of hPDGF-A-neutralizing antibody (final concentration ¼ 10 mg/ml; Abcam) was added to T-CM and the blocking effect was determined on days 1, 2 and 4.
K-B method
The above three kinds of CM were concentrated 20 times by lyophilizing and re-dissolving. Sterile filter paper disks were immersed in the concentrated CM with 10% trypsin, which were then put onto the Luria-Bertoni plates superficially containing P. aeruginosa, E. coli and S. aureus. After incubation at 37 1C for B10-12 h, pictures were taken for analyzing the bacteriostasis effect revealed by the width of the clear zones surrounding the disks.
Experimental animals and wound model
Sprague-Dawley (3 month old male) rats weighing between 180 and 220 g were supplied by the center of experimental animals in our university (qualified certification number: CQA 0101015# and 0103017#, Chongqing, China). The experimental protocol used in this study was approved by the Animal Care Committee of our university and was in agreement with 'Guide for the Care and Use of Laboratory Animals' published by the National Institutes of Health.
The rats were put into specially made Plexiglass boxes. The single-dose TBI injury was created using a 60 Co g-ray source at a dose rate of approximately 31 cGy/min and a dose of 6 Gy. Subsequently, the rats were anesthetized by an intraperitoneal injection of pentobarbital (30 mg/kg), and a full-thickness excisional skin wound 20 mm in diameter (about 2% of total body surface area) through the panniculus carnosus was made on the shaved dorsal back within 30 min after radiation injury. The animals were randomly divided into the following three groups: 
Parameters for assessing wound healing in vivo
For recording wound healing, animals with different manipulations (n ¼ 8 in each group) were set up separately. Images of the residual wound area were obtained using a digital camera under the same photographic conditions. Average wound healing time was determined. The digital analysis was carried out by investigators who were blinded to group assignments. Complete wound healing times were indicated by the shedding of scars and complete re-epithelialization of the wound bed. The re-epithelialized but unhaired skin area was recorded as zero. The percentage of residual wound area relative to the original area was calculated by image analysis software. For pathological studies and bacterial loads in wounds, 12 rats in each group were included. Three animals were killed at days 3, 7, 14 and 21 in each group. The wounds were harvested under sterile conditions. Wound tissue of 100 mg was used to determine the amount of bacteria under the scar, and the remaining wound tissue was separated into two parts. One part was fixed in formalin for the preparation of paraffinembedded wound tissue sections, which were used in histological studies with hemotoxylin-eosin staining and collagen analysis with Sirius red staining; the other part was immediately embedded with optimal cutting temperature medium and frozen in liquid nitrogen. Instant and direct observation of green fluorescence on frozen sections was performed to detect exogenous gene expression as well as the distribution of transplanted BMSCs by fluorescent microscopy.
Measurement of the amount of bacteria under the scar
Wound tissue of 100 mg under the scar was acquired at days 3, 7, 14 and 21 post transplantation and transferred into a glass homogenizer containing 1 ml of PBS and ground down. A portion of 10 ml homogenate diluted 10 times was spread onto three semisolid Luria-Bertoni plates for each sample. The number of bacterial colonies in the plate was counted after overnight incubation at 37 1C, and the bacterial colonies formed from one gram of wound tissue was obtained by multiplying the number with 10 4 .
Frozen tissue sections and Sirius red staining
Wound tissue was made into a frozen section of 7-mm thickness and then treated with 4,6-diamidino-2-phenylindole solution to label the cellular nucleus. Expression of GFP was evaluated by fluorescent microscopy. Sirius red staining was performed using the method described by Junqueira et al. 27 Paraffin-embedded slides were dehydrated and stained in Sirius red solution for 1 h. Collagen fibril thickness and alignment were observed by polarized light microscopy. The mean OD was blindly determined using Image-Pro Plus software.
Statistical analysis SPSS 13.0 was used to process the data. Univariate analysis of variance in general linear model was applied to test the statistical differences among means. The equality of variances was tested by Levene's test. Multiple comparisons of means were determined by hPDGF-A/hBD2 gene-modified BMSCs promote wound healing L Hao et al Tukey's honestly significant difference test and Tamhane's T2 of post hoc comparisons. Data were shown as mean ± s.d. Statistical significance was assumed at P-values less than 0.05.
